Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524480 | NSE Symbol : | ISIN : INE249D01019 | Industry : Trading |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
26-May-2025	29-May-2025	Final Dividend	Riddhi Siddhi Gluco Biols Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve 1. Audited Financial Results of the Company (Standalone and Consolidated) for the Quarter and Financial Year ended on 31st March 2025. 2. Dividend if any on Equity Shares of the Company for the Financial Year ended 31st March 2025. Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Of Riddhi Siddhi Gluco Biols Limited (Company) Held Today I.E. On Thursday 29Th May 2025. The Board has recommended dividend of Rs. 3/- per share i.e. 30 % on equity shares of the Company for the Financial Year ended on 31st March, 2025. (As Per BSE Announcement Dated on 29.05.2025)
30-Jan-2025	05-Feb-2025	Quarterly Results	RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve 1. To Consider and approve Unaudited Financial Results of the Company (Standalone and Consolidated) for the Quarter and nine months ended on 31st December 2024. 2. To adopt Limited Review Reports to be issued by Statutory Auditors of the Company on Standalone and Consolidated Financial Results for the Quarter and nine months ended on 31st December 2024. We hereby submit outcome of meeting of Board of Directors of Riddhi Siddhi Gluco Biols Limited held on Wednesday 05th February, 2025. (As Per BSE Announcement Dated on 05/02/2025)
04-Nov-2024	11-Nov-2024	Quarterly Results	RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30.09.2024 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), please find attached outcome of board meeting of Riddhi Siddhi Gluco Biols Limited (As per BSE Announcement Dated on 11/11/2024)
08-Aug-2024	14-Aug-2024	Quarterly Results	RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited Financial Results of the Company (Standalone and Consolidated) for the Quarter ended on 30th June 2024 Please find attached outcome of Board meeting held on Wednesday 14th August, 2024. (As per BSE Announcement Dated on 14/08/2024)
13-May-2024	20-May-2024	Final Dividend	RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 inter alia to consider and approve Audited Financial Results of the Company (Standalone and Consolidated) for the Quarter and Financial year ended 31st March 2024. With reference to above subject and in compliance with Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we hereby submit outcome of the meeting of the Board of Directors of the Company held on Monday, 20th May, 2024. Kindly update the same on your records (As Per BSE Announcement Dated on 20.05.2024)
18-May-2024	18-May-2024	Change in Directors	Appointment Mr. Pratik Shah (DIN: 01738382) as an Additional Non - Executive Director of the Company.
03-Feb-2024	10-Feb-2024	Quarterly Results	RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve Approval of unaudited standalone and consolidated finacial results fot the quarter and nine months ended 31.12.2023. Pursuant to Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we hereby submit outcome of meeting of Board of Directors of Company held on Saturday, 10th February, 2024. (As Per BSE Announcement dated on 10.02.2024)
28-Oct-2023	04-Nov-2023	Quarterly Results	RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 inter alia to consider and approve unaudited financial results (standalone & consolidated) for the quarter and half year ended on 30.09.2023. Pursuant to Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we hereby inform you that the Board of Directors of the Company has, inter alia, approved Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended on 30th September, 2023 along with Limited Review Reports issued by the Statutory Auditor. Pursuant to Regulation 30 & 33 of SEBI(LODR) Regulation,2015 we hereby inform you that the Board of Directors of the Company, approved and consider standalone and consolidated financial result for the quarter and half year ended on 30.09.2023 along with limited review reports issued by statutory auditor of the Company. (As per BSE Announcement Dated on 04/11/2023)
05-Aug-2023	11-Aug-2023	Quarterly Results	RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve Unaudited Financial Results of the Company (Standalone and Consolidated) for the Quarter ended on 30th June 2023 With reference to above subject and in compliance with the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we hereby submit outcome of the meeting of the Board of Directors of the Company held on Friday, 11th August, 2023. Pursuant to Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligation & Disclosure Requirements), Regulations, 2015, we hereby submit unaudited standalone and consolidated financial results for the quarter ended 30th June, 2023 along with limited review report thereon. The Board of Directors of the Company in its meeting held on Friday, 11th August, 2023, subject to the approval of shareholders, have approved the appointment of Mrs. Sangita Singhi (DIN: 06999605) as Additional Independent Director of the Company for a period of 5 years with effect from 11.08.2023. (As Per BSE Announcement dated on 11.08.2023)
23-May-2023	29-May-2023	Final Dividend	RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve Audited Financial Results of the Company (Standalone and Consolidated) for the Quarter and Financial year ended 31st March 2023. With reference to above subject and in compliance with Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we hereby submit outcome of the meeting of the Board of Directors of the Company held on Monday, 29th May, 2023. Kindly update the same on your records. Pursuant to Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we hereby inform you that the Board of Directors of the Company in its meting held on Monday, 29th May, 2023 has, inter alia, approved Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ended on 31st March, 2023 and adopted the Auditor's Reports thereon. Kindly update the same on your records. The Board of Directors of the Company in its meeting held on today i.e. Monday, 29th May, 2023 has recommended dividend of Rs. 1.50/- per share i.e. 15 % on Equity shares of the Company for the Financial Year ended 31st March, 2023. Kindly update the same on your records. With reference to above subject and in compliance with Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we hereby submit outcome of the meeting of the Board of Directors of the Company held on Monday, 29th May, 2023. Kindly update the same on your records. Pursuant to Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we hereby inform you that the Board of Directors of the Company in its meting held on Monday, 29th May, 2023 has, inter alia, approved Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ended on 31st March, 2023 and adopted the Auditor's Reports thereon. Kindly update the same on your records. Please find attached Corrigendum to Audited Standalone & Consolidated Financial Results of the Company for the quarter and financial year ended 31st March, 2023. (As Per BSE Announcement Dated on 29.05.2023)
24-Feb-2023	24-Feb-2023	Investments	Pursuant to Regulation 30 of Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in its Meeting held today has, inter-alia, considered and approved to enter into material related party transaction with Subsidiary Company viz. Shree Rama Newsprint Limited.
08-Feb-2023	14-Feb-2023	Quarterly Results	RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Unaudited Financial Results of the Company (Standalone and Consolidated) for the Quarter ended on 31st December 2022. Pursuant to Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we hereby inform you that the Board of Directors of the Company has, inter alia, approved Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine months ended on 31st December, 2022 along with Limited Review Reports issued by the Statutory Auditor M/s Batliboi & Purohit, Chartered Accountants, Mumbai (FRN: 101048W). Copy of the same is annexed herewith. Pursuant to Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we hereby inform you that the Board of Directors of the Company has, inter alia, approved Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine months ended on 31st December, 2022 along with Limited Review Reports issued by the Statutory Auditor M/s Batliboi & Purohit, Chartered Accountants, Mumbai (FRN: 101048W). Copy of the same is annexed herewith. (As Per BSE Announcement Dated on 14.02.2023)
07-Nov-2022	14-Nov-2022	Quarterly Results	RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Consider and approve Unaudited Financial Results of the Company (Standalone and Consolidated) for the Quarter and Half Year ended on 30th September 2022 Pursuant to Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we hereby inform you that the Board of Directors of the Company has, inter alia, approved Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended on 30th September, 2022 along with Limited Review Reports issued by the Statutory Auditor M/s Batliboi & Purohit, Chartered Accountants, Mumbai (FRN: 101048W). Copy of the same is annexed herewith. The meeting of the Board of Directors of the Company which was commenced at 05.15 P.M. and concluded at 5.35 P.M. Pursuant to Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we hereby inform you that the Board of Directors of the Company has, inter alia, approved Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended on 30th September, 2022 along with Limited Review Reports issued by the Statutory Auditor M/s Batliboi & Purohit, Chartered Accountants, Mumbai (FRN: 101048W). Copy of the same is annexed herewith. (As Per BSE Announcement Dated on 14.11.2022)
31-Jul-2022	06-Aug-2022	Quarterly Results	RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2022 inter alia to consider and approve Unaudited Financial Results of the Company (Standalone and Consolidated) for the Quarter ended on 30th June 2022 and To adopt Limited Review Reports to be issued by Statutory Auditors of the Company on Standalone and Consolidated Financial Results for the quarter ended on 30th June 2022. Pursuant to Regulation 30 & 33 of SEBI(LODR), 2015, we hereby submit outcome of Board meeting of the company held on Saturday, 6th August, 2022 which was commenced at 05.30 P.M. and concluded at 06.30 P.M. Please update the same in your records. Pursuant to Regulation 30 & 33 of SEBI(LODR), 2015, we hereby submit you Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter ended on 30th June, 2022 along with Limited Review Reports issued by the Statutory Auditor M/s Batliboi & Purohit, Chartered Accountants, Mumbai. Copy of the same is annexed herewith. Kindly update the same in your records. (As Per BSE Announcement Dated on 06/08/2022)
23-May-2022	30-May-2022	Accounts	RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve Audited Financial Results of the Company (Standalone and Consolidated) for the Quarter and Financial year ended on 31st March 2022. Notice is hereby given that pursuant to Regulation 29 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of Board of Directors of the Company is scheduled to be held on Monday, 30th May, 2022, inter alia: 1. To Consider and approve Audited Financial Results of the Company (Standalone and Consolidated) for the Quarter and Financial year ended on 31st March, 2022. 2. To consider and recommend dividend, if any, on equity shares of the Company for the Financial Year ended on 31st March, 2022. Kindly update the same on your records. (As Per BSE Announcement dated on 23.05.2022) The Board has recommended dividend of Rs. 1/- per shares on Equity shares of the Company for the Financial Year ended 31st March, 2022. Kindly update the same on your records. 1. Pursuant to Regulation 30 & 33 of Listing Regulations, we hereby inform you that the Board of Directors of the Company has, inter alia, approved Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ended on 31st March, 2022 and adopted the Auditor's Reports thereon. 2. The Board has recommended dividend of Rs. 1/- per shares on equity shares of the Company for the Financial Year ended 31st March, 2022. Kindly update the same on your records. Pursuant to Regulation 30 & 33 of Listing Regulations, we hereby inform you that the Board of Directors of the Company has, inter alia, approved Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ended on 31st March, 2022 and adopted the Auditor's Reports thereon. Kindly update the same on your records. (As per BSE Announcement Dated on 30/5/2022)

1 2

LOGIN HERE

Riddhi Siddhi Gluco Biols Ltd

Board Meeting